iSOFT Adds New Functionality to UK Laboratory Systems

iSOFT Group LimitediSOFT Group Limited, one of the world's largest healthcare IT companies, will release a series of new functions for its i.Laboratory range of pathology solutions and create a UK-based development team to advance the capability of the laboratory business to meet local needs.

The new modules for i.Laboratory will be available ahead of a major user group forum at the International Convention Centre (ICC) in Birmingham on 10-11 June. As well as a platform for demonstrating the new modules, iSOFT will also provide a forum for customers to inform future developments to realise the benefits of current systems.

To ensure iSOFT's UK customers remain at the forefront of laboratory information system technology (LIS), iSOFT has recently created a local development team in the UK. This will grow rapidly to provide a full laboratory development capacity focused on local requirements.

"These significant developments clearly demonstrate our commitment to LIS customers in the UK and Ireland and to growing our market share," said Adrian Stevens, Managing Director of iSOFT’s UK and Ireland business. "The investment in technology and people is a reflection of the importance of the UK LIS market to iSOFT and we will continue to invest to maintain our leadership position.

"The solutions being developed will provide significant new and updated functionality to meet customer needs and ensure they remain at the forefront of laboratory technology," Stevens said. "Our approach means that users can take immediate advantage of powerful new functionality that will begin their journey on to a technology platform designed for the next phase of the evolution of laboratory services in the UK and globally. This means that even as our customers implement discrete functionality to improve business performance in one area or discipline, they will be building the organisation-wide capability to help deliver a laboratory service of the future. The new offerings will help manage information and reduce the time to turnaround test results and will improve the quality of care and cut costs, which is vital in the current economic climate."

Separately iSOFT has also been awarded a contract by NHS Connecting for Health to develop a solution for GPs and other primary care users to request pathology tests and receive results online. The module will work with all major GP systems and is planned for full release in the second half of 2010.

iSOFT has 150 customers in the NHS and Ireland for its laboratory solutions, giving it a 65% share of the market.

The UK development team will create new functions for all i.Laboratory Apex and i.Laboratory TP users, including:

  • GP Test Results Requesting and Reporting
  • Full word processing and digital dictation for cellular pathology
  • Cancer Histopathology Reporting module
  • Dedicated laboratory interface manager
  • Standardised Business Intelligence
  • Infection control
  • Enhanced disease screening - eGFR, stroke risk calculation and CHD risk calculation
  • Cervical cytology
  • New and improved Graphical User Interface
  • Digital solutions for lab-to-lab interconnectivity
  • Configurable dashboards

"With a large installed base in Europe, iSOFT remains one of the continent's largest providers of laboratory information systems," said Gary Cohen, iSOFT's Executive Chairman and CEO. "These and other developments put us in prime position to capitalise on the growth in this sector and deliver solutions at a local and national level to meet the future needs of public and private laboratory services."

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in about 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...